Folliculitis
Conditions
Interventions
Control Group:Oral Fangfeng Tongsheng Powder + topical Mupirocin Ointment
Experimental Group:Oral Fangfeng Tongsheng Powder + topical Liu Shen Gel
Sponsors
Affiliated Hospital of North Sichuan Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Gender unrestricted, aged 18-65 years; (2) Meeting the Western diagnostic criteria for folliculitis as above; (3) Patients with grade II-III folliculitis outside the head and face; (4) No use of topical agents such as hormones, antibiotics, retinoids, or antifungals for skin infections within 2 weeks prior to enrollment; (5) Voluntary participation with signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with other skin diseases that may exacerbate the condition, or deemed by investigators to potentially affect trial outcome assessments; (2) Allergy to trial product or hypersensitive constitution; (3) Pregnant or lactating patients; (4) Patients who took oral antibiotics, antifungals, or other skin/soft tissue infection medications within 1 month prior to enrollment; (5) Patients who received physical therapy for folliculitis within 1 month prior to enrollment; or patients treated with salicylic acid/alpha hydroxy acids; (6) Patients with injection/surgical history at affected sites within 2 months prior to trial; (7) Patients with immunodeficiency diseases;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The overall clinical efficacy rate after 2 weeks of treatment.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lesion scoring before treatment, after 1 week of treatment, and after 2 weeks of treatment.;Recurrence after 3 and 6 months of treatment.; | — |
Countries
China
Contacts
Public ContactZhang Boda
Affiliated Hospital of North Sichuan Medical College
Outcome results
None listed